Found 7 matching trials
Phase III Confirmatory Study in Erythropoietic Protoporphyria
PHASE3This is a randomized placebo-controlled study to be conducted in two parall...
Location
University of Alabama
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
PHASE1The purpose of this study is to evaluate the concentration of afamelanotide...
Phase II Solar Urticaria (SU) Pilot Study
PHASE2Urticaria is one of the most common dermatological conditions with diverse ...
Location
Salford Royal Foundation Hospital (Hope Hospital)
Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
N/AThe purpose of this study is to determine whether the afamelanotide (CUV164...
Location
St Vincents Hospital
Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
PHASE3Afamelanotide is a man-made drug being studied for use as a preventative me...
Location
HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital)
Multicentre Phase III Erythropoietic Protoporphyria Study
PHASE3This was a phase III, multicentre, randomised, double-blind, placebo-contro...
Location
Multiple Locations
Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
PHASE2This is a randomized placebo-controlled study to be conducted in two parall...
Location
University of Alabama